It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
We present a droplet-based microfluidic system that enables CRISPR-based gene editing and high-throughput screening on a chip. The microfluidic device contains a 10 × 10 element array, and each element contains sets of electrodes for two electric field-actuated operations: electrowetting for merging droplets to mix reagents and electroporation for transformation. This device can perform up to 100 genetic modification reactions in parallel, providing a scalable platform for generating the large number of engineered strains required for the combinatorial optimization of genetic pathways and predictable bioengineering. We demonstrate the system’s capabilities through the CRISPR-based engineering of two test cases: (1) disruption of the function of the enzyme galactokinase (galK) in E. coli and (2) targeted engineering of the glutamine synthetase gene (glnA) and the blue-pigment synthetase gene (bpsA) to improve indigoidine production in E. coli.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 DOE Joint BioEnergy Institute, Technology Division, Emeryville, USA (GRID:grid.451372.6) (ISNI:0000 0004 0407 8980); Sandia National Laboratories, Biotechnology and Bioengineering Department, Livermore, USA (GRID:grid.474523.3) (ISNI:0000000403888279)
2 DOE Joint BioEnergy Institute, Biofuels and Bioproducts Division, Emeryville, USA (GRID:grid.451372.6) (ISNI:0000 0004 0407 8980); Lawrence Berkeley National Laboratory, Biological Systems and Engineering Division, Berkeley, USA (GRID:grid.184769.5) (ISNI:0000 0001 2231 4551)
3 DOE Joint BioEnergy Institute, Technology Division, Emeryville, USA (GRID:grid.451372.6) (ISNI:0000 0004 0407 8980); Lawrence Berkeley National Laboratory, Biological Systems and Engineering Division, Berkeley, USA (GRID:grid.184769.5) (ISNI:0000 0001 2231 4551)
4 DOE Joint BioEnergy Institute, Technology Division, Emeryville, USA (GRID:grid.451372.6) (ISNI:0000 0004 0407 8980); Lawrence Berkeley National Laboratory, Molecular Biophysics and Integrated Bioimaging Division, Berkeley, USA (GRID:grid.184769.5) (ISNI:0000 0001 2231 4551); University of California, Department of Bioengineering, Berkeley, USA (GRID:grid.47840.3f) (ISNI:0000 0001 2181 7878)
5 DOE Joint BioEnergy Institute, Biofuels and Bioproducts Division, Emeryville, USA (GRID:grid.451372.6) (ISNI:0000 0004 0407 8980); Lawrence Berkeley National Laboratory, Biological Systems and Engineering Division, Berkeley, USA (GRID:grid.184769.5) (ISNI:0000 0001 2231 4551); Basque Center for Applied Mathematics, BCAM, Bilbao, Spain (GRID:grid.462072.5) (ISNI:0000 0004 0467 2410)